Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H5N5O |
| Molecular Weight | 151.1261 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2)C(=O)N1
InChI
InChIKey=UYTPUPDQBNUYGX-UHFFFAOYSA-N
InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)
| Molecular Formula | C5H5N5O |
| Molecular Weight | 151.1261 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Base sequence-specific attack of stilbene estrogen metabolite(s) on the mitochondrial DNA: implications in the induction of instability in the mitochondrial genome in the kidney of Syrian hamsters. | 2001-04 |
|
| Reduction of BCNU toxicity to lung cells by high-level expression of O(6)-methylguanine-DNA methyltransferase. | 2001-04 |
|
| A-like guanine-guanine stacking in the aqueous DNA duplex of d(GGGGCCCC). | 2001-03-23 |
|
| Structure, folding and activity of the VS ribozyme: importance of the 2-3-6 helical junction. | 2001-03-15 |
|
| Affinity of mismatch-binding protein MutS for heteroduplexes containing different mismatches. | 2001-03-15 |
|
| Solution structure of an A-tract DNA bend. | 2001-03-09 |
|
| Characterization of cDNA encoding the human tRNA-guanine transglycosylase (TGT) catalytic subunit. | 2001-03-07 |
|
| The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents. | 2001-03-07 |
|
| Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage. | 2001-03-01 |
|
| Conjugative metabolism of 1,2-dibromoethane in mitochondria: disruption of oxidative phosphorylation and alkylation of mitochondrial DNA. | 2001-03-01 |
|
| A seminested PCR test for simultaneous detection of two common mutations (35delG and 167delT) in the connexin-26 gene. | 2001-03 |
|
| Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. | 2001-03 |
|
| New biochemical markers in Alzheimer disease. | 2001-03 |
|
| Substrate assisted catalysis -- application to G proteins. | 2001-03 |
|
| Metabolic fate of AMP, IMP, GMP and XMP in the cytosol of rat brain: an experimental and theoretical analysis. | 2001-03 |
|
| Metabolism of the beta-oxidized intermediates of N-nitrosodi-n-propylamine: N-nitroso-beta-hydroxypropylpropylamine and N-nitroso-beta-oxopropylpropylamine. | 2001-03 |
|
| Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. | 2001-03 |
|
| Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. | 2001-03 |
|
| Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. | 2001-03 |
|
| Inactivation of human O(6)-alkylguanine-DNA alkyltransferase by modified oligodeoxyribonucleotides containing O(6)-benzylguanine. | 2001-03 |
|
| Cloning and direct G-protein regulation of phospholipase D from tobacco. | 2001-02-26 |
|
| Characterization of the mouse liver fructose-1,6-bisphosphatase gene. | 2001-02-21 |
|
| Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. | 2001-02-16 |
|
| Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. | 2001-02-15 |
|
| Specific binding of 2-amino-1,8-naphthyridine into a single guanine bulge as evidenced by photooxidation of GG doublet. | 2001-02-12 |
|
| Oxidation kinetics of guanine in DNA molecules adsorbed onto indium tin oxide electrodes. | 2001-02-01 |
|
| Miscoding and misincorporation of 8-oxo-guanine during leading and lagging strand synthesis in Escherichia coli. | 2001-02 |
|
| Gemcitabine and Pemetrexed disodium in treating breast cancer. | 2001-02 |
|
| Alanine scan mutagenesis of the switch I domain of the Caulobacter crescentus CgtA protein reveals critical amino acids required for in vivo function. | 2001-02 |
|
| The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil. | 2001-02 |
|
| Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo. | 2001-02 |
|
| Genetic changes of hOGG1 and the activity of oh8Gua glycosylase in colon cancer. | 2001-02 |
|
| Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins. | 2001-02 |
|
| Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. | 2001-02 |
|
| Cisplatin-DNA cross-link retro models with a chirality-neutral carrier ligand: evidence for the importance of "second-sphere communication". | 2001-01-29 |
|
| The N-terminal domain of the Caulobacter crescentus CgtA protein does not function as a guanine nucleotide exchange factor. | 2001-01-26 |
|
| Genetic study of SOX9 in a case of campomelic dysplasia. | 2001-01-15 |
|
| DNA electrochemical biosensors. | 2001-01-01 |
|
| Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine. | 2001-01-01 |
|
| Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. | 2001-01-01 |
|
| Enhanced loop DNA folding induced by thymine-CH3 group contact and perpendicular guanine-thymine interaction. | 2001-01 |
|
| Evidence of a no-effect level in silica-induced rat lung mutagenicity but not in fibrogenicity. | 2001-01 |
|
| Quantum chemistry predicted correlations between geometric isomerism (conformation) of -OH and =NH substituents and typical group frequencies of nucleic acid bases: cytosine. | 2001-01 |
|
| Reduction of wobble-position GC bases in Corynebacteria genes and enhancement of PCR and heterologous expression. | 2001-01 |
|
| Spreadsheet-based program for the analysis of DNA methylation. | 2001-01 |
|
| Guanine versus deoxyribose damage in DNA oxidation mediated by vanadium(IV) and vanadium(V) complexes. | 2001-01 |
|
| UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. | 2001 |
|
| Regulation of gene expression by GC-rich DNA cis-elements. | 2001 |
|
| Sequence-specific DNA damage induced by UVA radiation in the presence of endogenous and exogenous photosensitizers. | 2001 |
|
| Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:18 GMT 2025
by
admin
on
Mon Mar 31 18:22:18 GMT 2025
|
| Record UNII |
5Z93L87A1R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
78695-4
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
||
|
NCI_THESAURUS |
C786
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
||
|
LOINC |
79690-4
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
||
|
LOINC |
79663-1
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m5869
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB02377
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
73-40-5
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
2127
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
1302156
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
5Z93L87A1R
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
D006147
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
135398634
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
1372539
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | RxNorm | ||
|
GUANINE
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
100000182768
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
DTXSID9052476
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
16235
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
C532
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
200-799-8
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
DERIVATIVE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
sum of impurities A and B: maximum 2.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
sum of impurities A and B: maximum 2.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
INTERNATIONAL PHARMACOPEIA
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|